Logo image of NWH-DB-H.CA

NORTHWEST HEALTHCARE PRO (NWH-DB-H.CA) Stock Overview

Canada - TSX:NWH-DB-H - CA667495AJ41

102 CAD
+0.01 (+0.01%)
Last: 10/16/2025, 7:00:00 PM
Fundamental Rating

2

NWH-DB-H gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 38 industry peers in the Diversified REITs industry. NWH-DB-H has a medium profitability rating, but doesn't score so well on its financial health evaluation. NWH-DB-H is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year NWH-DB-H has reported negative net income.
In the past year NWH-DB-H had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: NWH-DB-H reported negative net income in multiple years.
In the past 5 years NWH-DB-H always reported a positive cash flow from operatings.
NWH-DB-H.CA Yearly Net Income VS EBIT VS OCF VS FCFNWH-DB-H.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

NWH-DB-H has a Return On Assets (-1.76%) which is comparable to the rest of the industry.
With a Return On Equity value of -6.60%, NWH-DB-H is not doing good in the industry: 65.79% of the companies in the same industry are doing better.
NWH-DB-H has a Return On Invested Capital of 3.69%. This is comparable to the rest of the industry: NWH-DB-H outperforms 47.37% of its industry peers.
The Average Return On Invested Capital over the past 3 years for NWH-DB-H is below the industry average of 5.45%.
The last Return On Invested Capital (3.69%) for NWH-DB-H is above the 3 year average (3.39%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -1.76%
ROE -6.6%
ROIC 3.69%
ROA(3y)-2.92%
ROA(5y)0.56%
ROE(3y)-11.33%
ROE(5y)0.68%
ROIC(3y)3.39%
ROIC(5y)3.39%
NWH-DB-H.CA Yearly ROA, ROE, ROICNWH-DB-H.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

The Operating Margin of NWH-DB-H (60.94%) is better than 81.58% of its industry peers.
NWH-DB-H's Operating Margin has declined in the last couple of years.
With an excellent Gross Margin value of 74.56%, NWH-DB-H belongs to the best of the industry, outperforming 84.21% of the companies in the same industry.
In the last couple of years the Gross Margin of NWH-DB-H has remained more or less at the same level.
Industry RankSector Rank
OM 60.94%
PM (TTM) N/A
GM 74.56%
OM growth 3Y-1.83%
OM growth 5Y-2.07%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.75%
GM growth 5Y-0.16%
NWH-DB-H.CA Yearly Profit, Operating, Gross MarginsNWH-DB-H.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100

More info and screens

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NWH-DB-H is destroying value.
Compared to 1 year ago, NWH-DB-H has more shares outstanding
Compared to 5 years ago, NWH-DB-H has more shares outstanding
Compared to 1 year ago, NWH-DB-H has an improved debt to assets ratio.
NWH-DB-H.CA Yearly Shares OutstandingNWH-DB-H.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
NWH-DB-H.CA Yearly Total Debt VS Total AssetsNWH-DB-H.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

NWH-DB-H has an Altman-Z score of 3.37. This indicates that NWH-DB-H is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 3.37, NWH-DB-H belongs to the best of the industry, outperforming 92.11% of the companies in the same industry.
NWH-DB-H has a debt to FCF ratio of 22.09. This is a negative value and a sign of low solvency as NWH-DB-H would need 22.09 years to pay back of all of its debts.
NWH-DB-H has a Debt to FCF ratio of 22.09. This is in the lower half of the industry: NWH-DB-H underperforms 63.16% of its industry peers.
NWH-DB-H has a Debt/Equity ratio of 1.30. This is a high value indicating a heavy dependency on external financing.
NWH-DB-H's Debt to Equity ratio of 1.30 is on the low side compared to the rest of the industry. NWH-DB-H is outperformed by 60.53% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.3
Debt/FCF 22.09
Altman-Z 3.37
ROIC/WACC0.49
WACC7.57%
NWH-DB-H.CA Yearly LT Debt VS Equity VS FCFNWH-DB-H.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

NWH-DB-H has a Current Ratio of 0.12. This is a bad value and indicates that NWH-DB-H is not financially healthy enough and could expect problems in meeting its short term obligations.
NWH-DB-H has a Current ratio of 0.12. This is in the lower half of the industry: NWH-DB-H underperforms 65.79% of its industry peers.
NWH-DB-H has a Quick Ratio of 0.12. This is a bad value and indicates that NWH-DB-H is not financially healthy enough and could expect problems in meeting its short term obligations.
NWH-DB-H's Quick ratio of 0.12 is on the low side compared to the rest of the industry. NWH-DB-H is outperformed by 65.79% of its industry peers.
Industry RankSector Rank
Current Ratio 0.12
Quick Ratio 0.12
NWH-DB-H.CA Yearly Current Assets VS Current LiabilitesNWH-DB-H.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 76.03% over the past year.
The Revenue for NWH-DB-H has decreased by -33.53% in the past year. This is quite bad
NWH-DB-H shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.78% yearly.
EPS 1Y (TTM)76.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%115.11%
Revenue 1Y (TTM)-33.53%
Revenue growth 3Y7.27%
Revenue growth 5Y4.78%
Sales Q2Q%-60.82%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NWH-DB-H.CA Yearly Revenue VS EstimatesNWH-DB-H.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
NWH-DB-H.CA Yearly EPS VS EstimatesNWH-DB-H.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 0.5 1 1.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

NWH-DB-H reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NWH-DB-H.CA Price Earnings VS Forward Price EarningsNWH-DB-H.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

NWH-DB-H's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of NWH-DB-H indicates a rather expensive valuation: NWH-DB-H more expensive than 84.21% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 194.88
EV/EBITDA 109.09
NWH-DB-H.CA Per share dataNWH-DB-H.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 10.04%, NWH-DB-H is a good candidate for dividend investing.
NWH-DB-H's Dividend Yield is rather good when compared to the industry average which is at 7.95. NWH-DB-H pays more dividend than 92.11% of the companies in the same industry.
NWH-DB-H's Dividend Yield is rather good when compared to the S&P500 average which is at 2.36.
Industry RankSector Rank
Dividend Yield 10.04%

5.2 History

The dividend of NWH-DB-H decreases each year by -13.72%.
NWH-DB-H does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)-13.72%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

NWH-DB-H has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-74.08%
EPS Next 2YN/A
EPS Next 3YN/A
NWH-DB-H.CA Yearly Income VS Free CF VS DividendNWH-DB-H.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

More info and screens

NORTHWEST HEALTHCARE PRO

TSX:NWH-DB-H (10/16/2025, 7:00:00 PM)

102

+0.01 (+0.01%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)08-12 2025-08-12
Earnings (Next)11-11 2025-11-11
Inst Owners11.54%
Inst Owner ChangeN/A
Ins Owners0.39%
Ins Owner ChangeN/A
Market Cap25.40B
Analysts72
Price Target112.68 (10.47%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 10.04%
Yearly Dividend0.32
Dividend Growth(5Y)-13.72%
DP-74.08%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.66%
PT rev (3m)-3.05%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 60.41
P/FCF 194.88
P/OCF 192.36
P/B 16
P/tB 16.93
EV/EBITDA 109.09
EPS(TTM)-0.42
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.52
FCFY0.51%
OCF(TTM)0.53
OCFY0.52%
SpS1.69
BVpS6.37
TBVpS6.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.76%
ROE -6.6%
ROCE 5.12%
ROIC 3.69%
ROICexc 3.75%
ROICexgc 3.82%
OM 60.94%
PM (TTM) N/A
GM 74.56%
FCFM 31%
ROA(3y)-2.92%
ROA(5y)0.56%
ROE(3y)-11.33%
ROE(5y)0.68%
ROIC(3y)3.39%
ROIC(5y)3.39%
ROICexc(3y)3.42%
ROICexc(5y)3.44%
ROICexgc(3y)3.49%
ROICexgc(5y)3.51%
ROCE(3y)4.7%
ROCE(5y)4.71%
ROICexcg growth 3Y5.86%
ROICexcg growth 5Y0.71%
ROICexc growth 3Y6.01%
ROICexc growth 5Y0.84%
OM growth 3Y-1.83%
OM growth 5Y-2.07%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.75%
GM growth 5Y-0.16%
F-Score4
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 1.3
Debt/FCF 22.09
Debt/EBITDA 7.97
Cap/Depr 73.88%
Cap/Sales 0.41%
Interest Coverage 1.82
Cash Conversion 51.08%
Profit Quality N/A
Current Ratio 0.12
Quick Ratio 0.12
Altman-Z 3.37
F-Score4
WACC7.57%
ROIC/WACC0.49
Cap/Depr(3y)24.87%
Cap/Depr(5y)24.57%
Cap/Sales(3y)0.11%
Cap/Sales(5y)0.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)76.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%115.11%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-33.53%
Revenue growth 3Y7.27%
Revenue growth 5Y4.78%
Sales Q2Q%-60.82%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-36.67%
EBIT growth 3Y5.3%
EBIT growth 5Y2.61%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-26.25%
FCF growth 3Y-11.68%
FCF growth 5Y-7.73%
OCF growth 1Y-25.41%
OCF growth 3Y-11.5%
OCF growth 5Y-7.59%